This morning the House of Commons Health and Social Care Committee published its report Antimicrobial Resistance following a public inquiry held in June earlier this year.
The report calls upon the Government, and the Prime Minister, to urgently raise the priority of AMR, both nationally and on a global stage, and expresses the need for AMR to be firmly established as a ‘top five priority’.
In addition to urging the Prime Minister and her advisers to raise the profile of AMR, the report makes recommendations in a further five key areas:
- Priority and political leadership
- Pharmaceutical market failure
- Antimicrobial use in healthcare
- Antimicrobial use in animals
- Antimicrobials and the environment
Examples of recommendations include making changes to patent law and to the ways that pharmaceutical companies are reimbursed for new antimicrobial medicines, with a view to boosting further research and development on new antimicrobials. The report also looks at antibiotic use in farming and urges the Government to make a clear commitment that post-Brexit, any future trade deals will require meat and dairy produce imported into the UK to meet at least the same standards relating to antibiotic use which apply to meat and dairy products produced in the EU.
Commenting on the release of the report, Dr David Pye, Honorary Policy Officer of the Biochemical Society, said:
‘Antimicrobial Resistance is one of the greatest challenges of the modern world, with serious implications for global health, agriculture, and the environment. We are pleased that the Committee’s report recognises the seriousness of the situation. The Society supports the report’s call for the Government to provide a clear commitment to global leadership in ensuring that the profile of AMR is raised on an international scale. It is essential that efforts to tackle AMR are coordinated across multiple disciplines and government departments both within the UK and internationally. We therefore welcome the report’s recommendation for AMR to be firmly established as a ‘top five priority’.’
The Biochemical Society submitted a response to this inquiry and our full consultation response is available to read on our website.